Latest Articles

Viewpoints

Post-Operative Recovery of Gastric Motility in the Geriatric Patient

Post-Operative Recovery of Gastric Motility in the Geriatric Patient

Many changes occur in the gastrointestinal tract during the aging process that can directly impact gastric motility following surgery.

General Oncology Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients

Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients

Research highlights how lack of guidelines regarding illness and adequate staffing at hospitals may be reason for oncologists working while sick.

Viewpoints ASCO Calls for Medicaid Reform to Improve Cancer Care for Low-Income Americans

ASCO Calls for Medicaid Reform to Improve Cancer Care for Low-Income Americans

ASCO issued a new policy statement that outlines nine specific recommendations to reform Medicaid and improve treatment for low-income patients with cancer.

In the Clinic Inpatient Versus Outpatient Cancer Therapy: Costs, Benefits, and Risks

Inpatient Versus Outpatient Cancer Therapy: Costs, Benefits, and Risks

Oncology clinicians must balance the cost, benefit, and risk when comparing inpatient versus outpatient care for patients.

Viewpoints Activating CD103+ Dendritic Cells May Lead to Improved Immunotherapy for Variety of Cancers

Activating CD103+ Dendritic Cells May Lead to Improved Immunotherapy for Variety of Cancers

Researchers delineated the intratumoral dendritic cells population and identified CD103+ DCs, extremely sparse yet remarkably capable cytotoxic T cell (CTL) stimulators.

Viewpoints Biochemotherapy Shows Benefits in High-Risk Melanoma, But Newer Agents Will Get More Use

Biochemotherapy Shows Benefits in High-Risk Melanoma, But Newer Agents Will Get More Use

Biochemotherapy prolongs relapse-free survival in malignant melanoma compared with high-dose interferon, but newer agents are safer and more effective.

Endocrine Cancer Evaluating Benign Thyroid Nodules: The Appropriate Time Interval After Initial Fine Needle Aspiration

Evaluating Benign Thyroid Nodules: The Appropriate Time Interval After Initial Fine Needle Aspiration

Kenneth D. Burman, MD, discusses study suggesting that optimal time for repeat evaluation of benign thyroid nodules is 2 to 4 years.

Publishers Alliance Mining Cancer-Specific Disease Comorbidities from a Large Observational Health Database

Mining Cancer-Specific Disease Comorbidities from a Large Observational Health Database

[Cancer Informatics] When examined, cancer comorbidities can reveal valuable clues to understanding the underlying genetic mechanisms of cancers. The comorbidity patterns among different patient groups and the effect of age and gender on cancer comorbidity patterns are investigated.

Viewpoints Proton Beam Therapy for the Treatment of Cancer: Does the Cost Match the Value?

Proton Beam Therapy for the Treatment of Cancer: Does the Cost Match the Value?

Proton beam therapy (PBT) offers clear dosimetric advantages, but it's not clear that it is superior to less expensive modalities.

Viewpoints Talking to Patients About Integrative Oncology

Talking to Patients About Integrative Oncology

Alternative therapies may be safely combined with traditional cancer treatments.

Viewpoints Are We Listening to Our Teen and Young Adult Patients with Cancer?

Are We Listening to Our Teen and Young Adult Patients with Cancer?

Research indicates that teenage and young adult patients with cancer may need additional assistance to avoid succumbing to their disease.

Lymphoma Updated Recommendations for Staging, Evaluation of Hodgkin and Non-Hodgkin Lymphoma

Updated Recommendations for Staging, Evaluation of Hodgkin and Non-Hodgkin Lymphoma

International group of hematologists released recommendations for evaluation and treatment response to Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).

In the Clinic Iniparib May Be Effective as Salvage Therapy for Metastatic Triple-Negative Breast ​Cancer

Iniparib May Be Effective as Salvage Therapy for Metastatic Triple-Negative Breast ​Cancer

Despite promising results, iniparib was found to be ineffective as first-line therapy for patients with metastatic triple-negative breast cancer.

Viewpoints Attacking Acute Myelogenous Leukemia (AML) in a New Way: Early Results for AG-221 Show Promise

Attacking Acute Myelogenous Leukemia (AML) in a New Way: Early Results for AG-221 Show Promise

There is warranted excitement for AG-221, a drug recently granted fast track designation by the FDA for acute myelogenous leukemia (AML).

From The Advisory Board Targeted Immunotherapy for Prostate Cancer with PROSTVAC: Interview with Neal Shore, MD, FACS

Targeted Immunotherapy for Prostate Cancer with PROSTVAC: Interview with Neal Shore, MD, FACS

Neal D. Shore, MD, FACS, sits down with CTA to discuss PROSTVAC as a targeted immunotherapy for prostate cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs